G.K.Bio Sciences (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 05-07-2024
- Paid Up Capital ₹ 3.61 M
as on 05-07-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 7.00 M
as on 05-07-2024
- Revenue 11.47%
(FY 2015)
- Profit -91.57%
(FY 2015)
- Ebitda 4.54%
(FY 2015)
- Net Worth 1.34%
(FY 2015)
- Total Assets 7.01%
(FY 2015)
About G.K.Bio Sciences (India)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.61 M.
The company currently has active open charges totaling ₹7.00 M.
Guduru Lakshmi and Krishnam Guduru serve as directors at the Company.
- CIN/LLPIN
U01409TG2010PTC069260
- Company No.
069260
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2010
- Date of AGM
25 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does G.K.Bio Sciences (India) Private Limited offer?
G.K.Bio Sciences (India) Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Hand Sanitizers & Personal Hygiene, Organic Soap, Ayurvedic, Herbal Oils and Cosmetics, Ayurvedic Cosmetics, Pain Balm & Ointments, Cosmetics, Hair & Beauty Products, Hair Oil, Common Disease Medicines.
Who are the key members and board of directors at G.K.Bio Sciences (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Guduru Lakshmi  | Director | 02-Jul-2010 | Current |
| Krishnam Guduru | Director | 02-Jul-2010 | Current |
Financial Performance and Corporate Structure Insights of G.K.Bio Sciences (India).
G.K.Bio Sciences (India) Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 11.47% increase. The company also saw a substantial fall in profitability, with a 91.57% decrease in profit. The company's net worth moved up by a moderate rise of 1.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G.K.Bio Sciences (India)?
In 2017, G.K.Bio Sciences (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 24 Feb 2012 | ₹7.00 M | Open |
How Many Employees Work at G.K.Bio Sciences (India)?
Unlock and access historical data on people associated with G.K.Bio Sciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G.K.Bio Sciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G.K.Bio Sciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
